How many employees does Nurix Therapeutics, Inc. have?

Nurix Therapeutics, Inc. reported 317 employees for the fiscal year ending Nov 2025, in the annual report it filed on January 28, 2026. That is up 10.8% from a year earlier.

What is Nurix Therapeutics, Inc.'s revenue per employee?

Nurix Therapeutics, Inc. brought in $84.0M of revenue in fiscal Nov 2025, which is $265K per employee. That ranks 76 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Nurix Therapeutics, Inc. employees and revenue per employee

NRIX · Biotechnology · $2.32B market cap

Nurix Therapeutics, Inc. had 317 employees at the end of fiscal Nov 2025, up 10.8% from a year earlier. Revenue for the year was $84.0M, up 54.0% from a year earlier, or $265K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

317

+10.8% YoY

Revenue

$84.0M

+54.0% YoY

Revenue / employee

$265K

Peer median $459K

Rank in industry

76 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Nov 2020

Hover a year for the numbers.

NRIX employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Nov 2025	317	$84.0M	$265K	+10.8%	+54.0%
Nov 2024	286	$54.5M	$191K	+0.7%	-29.1%
Nov 2023	284	$77.0M	$271K	-4.4%	+99.3%
Nov 2022	297	$38.6M	$130K	+22.7%	+29.8%
Nov 2021	242	$29.8M	$123K	+79.3%	+66.9%
Nov 2020	135	$17.8M	$132K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Nurix Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
ASMB Assembly Biosciences, Inc.	73	$72.3M	$990K	Leaner
AMLX Amylyx Pharmaceuticals, Inc.	123	$87.4M	$710K	Contracting
FDMT 4D Molecular Therapeutics, Inc.	196	$85.2M	$435K	Leaner
VRDN Viridian Therapeutics, Inc.	252	$70.8M	$281K	Efficient growth
NRIX Nurix Therapeutics, Inc.	317	$84.0M	$265K	Efficient growth
MGTX MeiraGTx Holdings plc	400	$81.4M	$203K	Efficient growth
VIR Vir Biotechnology, Inc.	367	$68.6M	$187K	Contracting
NTLA Intellia Therapeutics, Inc.	377	$67.7M	$179K	Leaner
CYTK Cytokinetics, Incorporated	673	$88.0M	$131K	Efficient growth

Every Healthcare company

Questions about Nurix Therapeutics, Inc.

How many employees does Nurix Therapeutics, Inc. have?: Nurix Therapeutics, Inc. reported 317 employees for the fiscal year ending Nov 2025, in the annual report it filed on January 28, 2026. That is up 10.8% from a year earlier.
What is Nurix Therapeutics, Inc.'s revenue per employee?: Nurix Therapeutics, Inc. brought in $84.0M of revenue in fiscal Nov 2025, which is $265K per employee. That ranks 76 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare NRIX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Nurix Therapeutics, Inc.'s annual reports (Form 10-K), latest filed January 28, 2026. This is data, not a recommendation to buy or sell NRIX.